Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial results evaluating metformin in combination with chemotherapy for patients with stage III–IV ovarian, fallopian tube,…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer [Phase 1]
Phase 1 clinical trial update on the safety and immunogenicity of Innocell Autologous Cellular Immunotherapy for recurrent epithelial ovaria…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 clinical trial update for GB-5267 in platinum-resistant ovarian, peritoneal, or fallopian tube cancer; the study is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 study is investigating Benmelstobart in combination with Anlotinib and oral metronomic cyclophosphamide for recurrent epithelial o…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer [Phase 3]
An ongoing Phase 3 trial evaluates the PARP inhibitor olaparib, alone or with bevacizumab, for patients with ovarian, fallopian tube, or pri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion [Phase 2]
Phase 2 trial evaluating APL-2 with pembrolizumab versus APL-2 with pembrolizumab plus bevacizumab versus bevacizumab alone for recurrent ov…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial completed to assess feasibility and quality of life of a second-look laparoscopy with hyperthermic intraperitoneal chemotherap…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
This update reports results from the Rucaparib Access Program (RAP) in Spain, summarizing clinical experience with rucaparib in patients wit…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dual-targeting CAR-NK cells against MSLN, FRα, and MUC16 for recurrent epithelial ovarian cancer, primar…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) [Phase 3]
Phase 3 clinical trial evaluating Olvi-Vec in combination with platinum-doublet chemotherapy and Bevacizumab versus physician's choice of ch…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
ART0380 is being studied in a Phase 1/2 trial for various advanced or metastatic solid tumors and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer [NA]
Clinical trial update on risk-reducing strategies, including fimbriectomy, for women with germline mutations predisposing to ovarian or pelv…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating MUC1-Activated T Cells for relapsed and resistant ovarian, fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluates a PARP inhibitor with or without an angiogenesis inhibitor in patients with homologous recombinat…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma [Phase 1]
Phase 1 clinical trial investigating intraperitoneal PX with nab-paclitaxel for peritoneal metastatic cancer; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This document describes a Phase 1 trial evaluating the combination of niraparib and copanlisib in patients with recurrent endometrial, ovari…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
This is a clinical trial update on a Phase 1/2 study evaluating pamiparib plus surufatinib for platinum-resistant ovarian cancer and related…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Depression Treatment and Screening in Ovarian Cancer Patients [Phase 1]
A Phase 1 clinical trial update investigating depression treatment and screening in patients with ovarian cancer and related cancers; the st…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial [Phase 3]
This update notes an ongoing Phase 3 trial evaluating minimally invasive surgery after neoadjuvant chemotherapy for advanced ovarian, fallop…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating surgery and chemotherapy with or without additional chemotherapy after surgery for ovarian, fallopian tube, uterine…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Lorigerlimab in Participants With Advanced Solid Tumors [Phase 2]
This is a Phase 2 clinical trial update for Lorigerlimab in participants with advanced solid tumors, currently recruiting, including platinu…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
This clinical trial update describes characterizing epithelial ovarian cancer patients by homologous recombination phenotype. The study is c…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer [Phase 2]
This is a Phase 2 neoadjuvant trial evaluating Aitua, a PD-1/CTLA-4 bispecific, with nab-paclitaxel and carboplatin in advanced high-grade s…